Blog | Rigorous research, robust insights: 2021 GTMRx Evidence Document represents significant changes in how we assess CMM
By: Marcia Buck, PharmD, FCCP, FPPAG, BCPPS Director of Clinical Practice Advancement American College of Clinical Pharmacy November 17, 2021 Rigorous research, robust insights: 2021 GTMRx Evidence Document represents significant changes in how we assess CMM The forthcoming 2021 GTMRx Evidence…